Florian Gossart

Scientist I, QC

Greater Toronto Area, Canada

About

Experience

  • BlueRock Therapeutics (Permanent Full-time · 4 yrs 6 mos)
    • Scientist 1, QC
      Sep 2025 - Present · 10 mos

      - Scheduling of daily activities for potency and cell biology assay team - Test Method Transfer from/to sending receiving units - Qualification of cell based assay and potency methods - SME and qualified trainer on cell based, cell count and potency test method and instrument usage - Test Method performance monitoring - Writing & reviewing of all associated documents - Lead quality event resolution such as change controls, deviations, CAPAs, lab investigations for atypical results - Review of executed quality documents such as QC test methods and logbooks - Experience with Veeva and MasterControl QMS softwares

    • Principal Analytical Specialist, QC
      Jan 2022 - Nov 2025 · 3 yrs 11 mos

      - Test Method Transfer from Assay Development team - Test Method Qualification - Test Method and Instrument Training - Test Method performance monitoring - Reference standards/reagents qualification and trending - Writing & reviewing of all associated documents - Lead quality event resolution such as change controls, deviations, CAPAs, lab investigations for atypical results - Review of executed quality documents such as QC test methods and logbooks - Experience with Veeva and MasterControl QMS softwares

  • Reasearch Associate Scientist at Providence Therapeutics
    Aug 2019 - Jan 2022 · 2 yrs 6 mos

    - Implementation of mRNA manufacturing at GMP standards - Support GDP implementation, manufacturing team coordination and sample logistics - Production of mRNA batches for phase I & II clinical trials - Development, implementation and training on in-process control and release test methods including qPCR for residual testing, dot blot, capillary electrophoresis, fluorescence/plate assays, in vitro translation and SDS page, visual inspection and extractable volume… - Authorship of production batch records, analytical method SOPs, and equipment use and maintenance SOPs - Authorship of analytical method qualification protocols and reports - Equipment owner responsible for equipment qualification and preventative maintenance tracking - Design of personnel flow and environmental monitoring plan for GMP manufacturing area

  • Consultant at CONSULTYS
    May 2017 - Oct 2018 · 1 yr 6 mos

    Consulting in Pharmaceutical industry From April to October 2018, Project coordinator for QC Analytical Support at Sanofi Pasteur Val-de-Reuil: - Global quality documents gap analyses and risk assessments - Updates and Harmonization of site quality documents - QC method simplification, creation of method flowcharts with Visio - Creation and management of a QC SharePoint - Participating in analytical strategy to answer audit observation From June 2017 to March 2018, Project coordinator for global MTech at Sanofi Pasteur Val-de-Reuil: - management of new technologies network

  • V.I.E : Associate Scientist at Sanofi Pasteur
    May 2015 - Apr 2017 · 2 yrs

    Development of analytical assays for novel protein and virus-based vaccines. _ Implementation of a test for the detection of mycoplasma by Agar and Broth Culture Method (ABCM) _ Implementation of a test for the detection on mycoplasma by Indicator Cell Culture Method (ICCM) _ Evaluation of the robustness of the mycoplasma detection test by PCR and microarray (NAT) _ Preparation of mycoplasma stocks and characterization for identity, titer and QC/CFU ratio. Qualification of the stocks _ Mycoplasma stock stability investigation and spiked samples holding time study _ Preparation of the parallel validation for the 3 mycoplasma detection tests (ABCM, ICCM, NAT) _ Writing of associated documents : procedures, worksheets, instructions, validation protocol, development report _ Routine Sequencing of bacterial stocks and identity/purity verification (Illumina NextSeq) _ Setting of a lab room with equipment validation monitoring

  • Superior Technician at Sanofi Pasteur
    Oct 2014 - Nov 2014 · 2 mos

    _ Evaluation of the Argus – Whole Genome Mapping technology for bacterial typing of wild type, recombinant and vaccine strains. Comparison between Argus results and PFGE _ Evaluation of the technology for genetic stability among clones. Comparison between Argus and PFGE + Southern blot. _ Use of the in silico function of the software to facilitate the sequence alignment after HTS. _ Culture and conservation of bacterial strains used for the studies _ Co-writing of an evaluation report